How Connelly was paid
$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Robert ConnellyPresident, Chief Executive Officer, and Director | $632,700 | $906,960 | $348,000 | — | $1,887,660 |
| Preetam Shah, Ph.D.Chief Strategy and Financial Officer and Treasurer | $350,612 | $796,143 | $201,600 | $29,331 | $1,377,686 |
| Christopher Haqq, M.D., Ph.D.Executive Vice President, Head of Research and Development and Chief Medical Officer | $528,100 | $328,176 | $221,900 | — | $1,078,176 |
What changed and why
- $1.9M$1,887,660 was Robert Connelly’s 2025 total compensation, versus $2,036,441 in 2024.
- $907K$906,960 was Connelly’s 2025 option-award compensation.
- $348K$348,000 was Connelly’s 2025 discretionary bonus based on 2025 corporate goals.
- $29,331$29,331 was Preetam Shah’s 2025 COBRA and existing-health-coverage reimbursement.
- 105%105% of target was the 2025 bonus payout for Shah and Christopher Haqq.
- February 2025 option grants were made to Connelly, Shah, and Haqq under the company’s equity plans.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.